Dr. Ledford specializes in studying the role of endogenous lung proteins and the mechanisms by which they mediate various states of lung inflammation, pathogen infection, and lung disease progression using pre-clinical animal models. Her translational research investigates obstructive lung disease and dysfunction of innate immunity in asthma and respiratory infections. With over a decade of experience mentoring and training medical students, graduate students, postdocs, and fellows, Dr. Ledford has a strong history of collaborative co-publications in the field of lung function and asthma. She is a co-founder of and serves as the Chief Scientific Officer of RaeSedo, Inc and a co-founder at Aspiro Therapeutics.